Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epigallocatechin-3-gallate (EGCG) and epicatechin are the primary polyphenolic flavonoids found in green tea (Camellia sinensis) and are the most studied components of the flavonoid antioxidant system. These compounds function as potent antioxidants by directly neutralizing reactive oxygen species (ROS) and chelating transition metals, thereby protecting cellular lipids, proteins, and DNA from oxidative damage (PubChem, 2024). Beyond direct scavenging, they act as bioactive modulators of cellular signaling, most notably by activating the Nrf2 pathway to upregulate endogenous antioxidant enzymes and inhibiting pro-inflammatory pathways like NF-kappaB (PubMed, PMC6073177). EGCG has also been identified as a high-affinity ligand for the 67-kDa laminin receptor, which plays a role in its anti-cancer and anti-metastatic effects (Nature, 2004). In cardiovascular health, epicatechin is known to enhance the bioactivity of endothelial nitric oxide synthase, supporting vascular relaxation (PubMed, 21477653). While these compounds show significant therapeutic potential in preventing chronic diseases such as cancer and neurodegeneration, their clinical application is often limited by poor bioavailability and concerns regarding liver toxicity at high supplemental doses (EFSA, 2018).
Direct scavenging of reactive oxygen species (ROS); activation of the Nrf2/ARE (Nuclear factor erythroid 2-related factor 2 / Antioxidant Response Element) signaling pathway; binding to the 67-kDa laminin receptor (67LR); inhibition of pro-inflammatory transcription factors such as NF-kappaB and AP-1; and inhibition of DNA methyltransferases (DNMTs).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epigallocatechin-3-gallate and Epicatechin (Flavonoid Antioxidant System) (EGCG/EC).